×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NVO – novo nordisk a/s (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NVO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
07:31 pm
nvo
FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors [Yahoo! Finance]
Low
Report
FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors [Yahoo! Finance]
12/20
06:58 pm
nvo
Eli Lilly's obesity drug Zepbound gains approval to treat sleep apnea [USA TODAY]
Neutral
Report
Eli Lilly's obesity drug Zepbound gains approval to treat sleep apnea [USA TODAY]
12/20
06:45 pm
nvo
Why Viking Therapeutics Tumbled by More Than 10% This Week [Yahoo! Finance]
Low
Report
Why Viking Therapeutics Tumbled by More Than 10% This Week [Yahoo! Finance]
12/20
04:06 pm
nvo
Stock market today: Dow, S&P 500, Nasdaq rebound on fresh inflation data to cap volatile week [Yahoo! Finance Canada]
Neutral
Report
Stock market today: Dow, S&P 500, Nasdaq rebound on fresh inflation data to cap volatile week [Yahoo! Finance Canada]
12/20
01:04 pm
nvo
Yahoo Finance [Yahoo! Finance]
Neutral
Report
Yahoo Finance [Yahoo! Finance]
12/20
12:52 pm
nvo
Novo Nordisk shares tumble as data on weight-loss drug trial disappoints [Financial Times (FT.com) (UK)]
Low
Report
Novo Nordisk shares tumble as data on weight-loss drug trial disappoints [Financial Times (FT.com) (UK)]
12/20
12:25 pm
nvo
Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps [MSNBC.com]
Low
Report
Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps [MSNBC.com]
12/20
12:19 pm
nvo
European Stocks Suffer Worst Week Since September as Novo Sinks [Yahoo! Finance]
Low
Report
European Stocks Suffer Worst Week Since September as Novo Sinks [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/20
08:30 am
nvo
Form 6-K NOVO NORDISK A S For: Dec 20
Low
Report
Form 6-K NOVO NORDISK A S For: Dec 20
12/20
08:26 am
nvo
Form 6-K NOVO NORDISK A S For: Dec 20
Low
Report
Form 6-K NOVO NORDISK A S For: Dec 20
12/18
01:50 pm
nvo
Form 6-K NOVO NORDISK A S For: Dec 18
Low
Report
Form 6-K NOVO NORDISK A S For: Dec 18
12/16
08:38 am
nvo
Form 6-K NOVO NORDISK A S For: Dec 16
Low
Report
Form 6-K NOVO NORDISK A S For: Dec 16
12/16
08:29 am
nvo
Form 6-K NOVO NORDISK A S For: Dec 14
Low
Report
Form 6-K NOVO NORDISK A S For: Dec 14
12/13
06:04 am
nvo
Form 6-K NOVO NORDISK A S For: Dec 12
Low
Report
Form 6-K NOVO NORDISK A S For: Dec 12
12/9
12:03 pm
nvo
Form 6-K NOVO NORDISK A S For: Dec 09
Low
Report
Form 6-K NOVO NORDISK A S For: Dec 09
12/6
02:34 pm
nvo
Form 6-K NOVO NORDISK A S For: Dec 06
Low
Report
Form 6-K NOVO NORDISK A S For: Dec 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/17
Form 6-K NOVO NORDISK A S For: Mar 16
6.0%
3/16 Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Bank of America Corp from a "neutral" rating to a "buy" rating. 4.7%
2/5 Q4/2019 12/31/2019 EPS 3.700 ZacksConsensus 0.550 ActVsEst 3.150 - Beat 4.6%
6/8 Novo's oral semaglutide successful in two late-stage T2D studies [Seeking Alpha] 3.8%
11/8 Novo Nordisk: Actual Numbers Not As Good As Headlines But Still Quite Solid [Seeking Alpha] 3.2%
3/27 Form 6-K NOVO NORDISK A S For: Mar 26 3.2%
8/12 Q2/2019 6/30/2019 EPS 4.030 ZacksConsensus 0.610 ActVsEst 3.420 - Beat 3.0%
9/17 With a backup to the backup, insulin makers say they're primed for Brexit [Reuters (UK)] 3.0%
11/1 Form 6-K NOVO NORDISK A S For: Nov 01 2.7%
8/8 Europe stocks climb in early action, led by pharmas [MarketWatch] 2.4%
3/16 Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Bank of America Corp from a "neutral" rating to a "buy" rating. 4.7%
2/5 Q4/2019 12/31/2019 EPS 3.700 ZacksConsensus 0.550 ActVsEst 3.150 - Beat 4.6%
6/8 Novo's oral semaglutide successful in two late-stage T2D studies [Seeking Alpha] 3.8%
11/8 Novo Nordisk: Actual Numbers Not As Good As Headlines But Still Quite Solid [Seeking Alpha] 3.2%
3/27 Form 6-K NOVO NORDISK A S For: Mar 26 3.2%
8/12 Q2/2019 6/30/2019 EPS 4.030 ZacksConsensus 0.610 ActVsEst 3.420 - Beat 3.0%
9/17 With a backup to the backup, insulin makers say they're primed for Brexit [Reuters (UK)] 3.0%
11/1 Form 6-K NOVO NORDISK A S For: Nov 01 2.7%
8/8 Europe stocks climb in early action, led by pharmas [MarketWatch] 2.4%
TOP News Decliners
9/9
Form 6-K NOVO NORDISK A S For: Sep 09
-3.6%
11/20 Form 6-K NOVO NORDISK A S For: Nov 20 -2.8%
12/18 Form 6-K NOVO NORDISK A S For: Dec 16 -2.5%
3/9 Form 6-K NOVO NORDISK A S For: Mar 09 -2.4%
4/7 Team Novo Nordisk and Beyond Type 1 Announce New Partnership -2.4%
1/3 Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward [Yahoo! Finance News] -2.2%
4/28 Form 6-K NOVO NORDISK A S For: Apr 27 -2.1%
9/10 Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -2.1%
3/23 Form 6-K NOVO NORDISK A S For: Mar 23 -1.8%
10/1 Form 6-K NOVO NORDISK A S For: Sep 30 -1.6%
11/20 Form 6-K NOVO NORDISK A S For: Nov 20 -2.8%
12/18 Form 6-K NOVO NORDISK A S For: Dec 16 -2.5%
3/9 Form 6-K NOVO NORDISK A S For: Mar 09 -2.4%
4/7 Team Novo Nordisk and Beyond Type 1 Announce New Partnership -2.4%
1/3 Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward [Yahoo! Finance News] -2.2%
4/28 Form 6-K NOVO NORDISK A S For: Apr 27 -2.1%
9/10 Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -2.1%
3/23 Form 6-K NOVO NORDISK A S For: Mar 23 -1.8%
10/1 Form 6-K NOVO NORDISK A S For: Sep 30 -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: